Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2018

01-11-2018 | Concise Research Reports

Prevalence of Behavioral Health Conditions Across Frequency of Cannabis Use Among Adult Primary Care Patients in Washington State

Authors: Gwen T. Lapham, PhD, MPH MSW, Amy K. Lee, MPH, Ryan M. Caldeiro, MD, Joseph E. Glass, PhD MSW, David S. Carrell, PhD, Julie E. Richards, MPH, Katharine A. Bradley, MD, MPH

Published in: Journal of General Internal Medicine | Issue 11/2018

Login to get access

Excerpt

Cannabis is the third most commonly used drug in the USA, after alcohol and tobacco, and the prevalence of cannabis use and cannabis use disorders (CUD) has doubled in the last decade, due in part to increasingly legalized access.1,2 Individuals who use cannabis have increased risk of behavioral health conditions, including depression, anxiety, and tobacco, alcohol, and other substance use disorders,35 but little is known about the association between frequency of cannabis use and behavioral health conditions among primary care patients. This population-based study of primary care patients6 reports on the prevalence of common behavioral health conditions across cannabis use frequency. …
Literature
2.
go back to reference Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 2016;173(6):588–599.CrossRef Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 2016;173(6):588–599.CrossRef
3.
go back to reference Pacek LR, Martins SS, Crum RM. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord 2013;148(2–3):188–195.CrossRef Pacek LR, Martins SS, Crum RM. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. J Affect Disord 2013;148(2–3):188–195.CrossRef
4.
go back to reference Blanco C, Hasin DS, Wall MM, et al. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry 2016;73(4):388–395.CrossRef Blanco C, Hasin DS, Wall MM, et al. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry 2016;73(4):388–395.CrossRef
5.
go back to reference Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2014;44(4):797–810.CrossRef Lev-Ran S, Roerecke M, Le Foll B, George TP, McKenzie K, Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2014;44(4):797–810.CrossRef
6.
go back to reference Lapham GT, Lee AK, Caldeiro RM, et al. Frequency of Cannabis Use Among Primary Care Patients in Washington State. J Am Board Fam Med 2017;30(6):795–805.CrossRef Lapham GT, Lee AK, Caldeiro RM, et al. Frequency of Cannabis Use Among Primary Care Patients in Washington State. J Am Board Fam Med 2017;30(6):795–805.CrossRef
Metadata
Title
Prevalence of Behavioral Health Conditions Across Frequency of Cannabis Use Among Adult Primary Care Patients in Washington State
Authors
Gwen T. Lapham, PhD, MPH MSW
Amy K. Lee, MPH
Ryan M. Caldeiro, MD
Joseph E. Glass, PhD MSW
David S. Carrell, PhD
Julie E. Richards, MPH
Katharine A. Bradley, MD, MPH
Publication date
01-11-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4558-8

Other articles of this Issue 11/2018

Journal of General Internal Medicine 11/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.